Top Markets
#1 Trillions Trillions +4,372.14%
#2 Ozapay Ozapay +38.75%
#3 Aria.AI Aria.AI +21.09%
#4 TRIA TRIA +14.07%
#5 Zano Zano +12.87%
#6 Osaka Protocol Osaka Protocol +11.93%
#7 DeXe DeXe +11.67%
#8 River Pts River Pts +11.61%
#9 pippin pippin +11.02%
#10 StakeStone StakeStone +10.06%
Coin of the day
Trillions Trillions
Settings
Language
ENGLISH
Currency
USD
Theme
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rank in Stocks #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Share Price
$0.28545656
Market Cap
$4.50M
Change (1 day)
5.97%
Change (1 year)
0.00%
Country
FR
Trade Acticor Biotech SAS (ALACT)

Category

Healthcare
Stock price history for Acticor Biotech SAS (ALACT)
Highest end of day price: $0.29 on 2024-12-01

Lowest end of day price: $7.56 on 2021-11-01
Stock price history of Acticor Biotech SAS from 2021 to 2026
Annual Stock Price Performance
Year Performance
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $36.56 -53.72%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $451.21 -11.96%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $738.62 9.85%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $297.61 51.31%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $94.95 -40.77%
AU